The investigation of melatonin effect on liver antioxidant and oxidant levels in fructose-mediated metabolic syndrome model

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 10, 2015, Pages 1915-1921

  Demirtas, C Y ^a   Pasaoglu, O T ^a   Bircan, F S ^a   Kantar, S ^a   Turkozkan, N ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Fructose; Liver; Melatonin; Metabolic syndrome; Oxidative stress

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CATALASE; FRUCTOSE; GLUCOSE; GLUTATHIONE PEROXIDASE; INSULIN; MELATONIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; ANTIOXIDANT; OXIDIZING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FLUID INTAKE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIVER; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; RAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; DISEASE MODEL; DRUG EFFECTS; INSULIN RESISTANCE; MALE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; FRUCTOSE; INSULIN RESISTANCE; LIVER; MALE; MELATONIN; METABOLIC SYNDROME X; OXIDANTS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84942080658     PISSN: 11283602     EISSN: 22840729     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. KASSI E, PERVANIDOU P KALTSAS G, CHROUSOS G. Metabolic syndrome: definitions and controversies. BMC Med 2011;5:9-48.
2. ROBERTS CK, SINDHU KK. Oxidative stress and metabolic syndrome. Life Sci 2009;84:705-712.
3. ELKS CM, FRANCIS J. Central adiposity, systemic inflammation, and the metabolic syndrome. Curr Hypertens Rep 2010;12:99-104.
4. STANHOPE KL, HAVEL PJ. Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup. Am J Clin Nutr 2008;88:1733-1737.
5. SWARBRICK MM, STANHOPE KL, ELLIOTT SS, GRAHAM JL, KRAUSS RM, CHRISTIANSEN MP GRIFFEN SC, KEIM NL, HAVEL PJ. Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. Br J Nutr 2008;100:947-952.
6. TEFF KL, GRUDZIAKJ, TOWNSEND RR, DUNN TN, GRANT RW ADAMS SH, KEIM NL, CUMMINGS BP STANHOPE KL, HAVEL PJ. Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. J Clin Endocrinol Metab 2009;94:1562-1569.
7. PEREZ-POZO SE, SCHOLD J, NAKAGAWA T, SÁNCHEZ-LOZADA LG, JOHNSON RJ, LILLO JL. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes 2010;34:454-461.
8. STANHOPE KL, HAVEL PJ. Fructose consumption: considerations for future research on its effects on adipose distribution, lipid metabolism, and insulin sensitivity in humans. J Nutr 2009;139:1236-1241.
9. DEKKER MJ, SU Q, BAKER C, RUTLEDGE AC, ADELI K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2010;299:E685-694.
10. MILLER A, ADELI K. Dietary fructose and the metabolic syndrome. Curr Opin Gastroenterol 2008;24:204-209.
11. KORKMAZ A, TOPAL T, TAN DX, REITER RJ. Role of melatonin in metabolic regulation. Rev Endocr Metab Disord 2009;10:261-270.
12. HOPPS E, NOTO D, CAIMI G, AVERNA MR. A novel component of the metabolic syndrome: the oxidative stress. Nutr Metab Cardiovasc Dis 2010;20:72-77.
13. ELNAKISH MT, HASSANAIN HH, JANSSEN PM, ANGELOS MG, KHAN M. Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase. J Pathol 2013;231:290-300.
14. SURH Y. Transcriptional realated of cellular antioxi-dant defence mechanism. Oxidative stress, inflammation and Health. Boca - Raton, CRC Press, 2005; pp. 21-40.
15. HASHEMI M, KORDI-TAMANDANI DM, SHARIFI N, MOAZENI-ROODI A, KAYKHAEI MA, NAROUIE B, TORK-MANZEHI A. Serum paraoxonase and arylesterase activities in metabolic syndrome in Zahedan, southeast Iran. Eur J Endocrinol 2011;164:219-222.
16. MACKNESS B, QUARCK R, VERRETH W, MACKNESS M, HOLVOET P. Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome. Arterioscler Thromb Vasc Biol 2006;26:1545-1550.
17. FERRÉ N, FELIU A, GARCÍA-HEREDIA A, MARSILLACH J, PARÍS N, ZARAGOZA-JORDANA M, MACKNESS B, MACK-NESS M, ESCRIBANO J, CLOSA-MONASTEROLO R, JOVEN J, CAMPS J. Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome. Clin Biochem 2013;46:1830-1836.
18. COSTA LG, VITALONE A, COLE TB, FURLONG CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005;69:541-550.
19. CAGNACCI A, CANNOLETTA M, RENZI A, BALDASSARI F, ARANGINO S, VOLPE A. Prolonged melatonin administration decreases nocturnal blood pressure in women. Am J Hypertens 2005;18:1614-1618.
20. HUANG L, ZHANG C, HOU Y, LAUDON M, SHE M, YANG S, DING L, WANG H, WANG Z, HE P, YIN W. Blood pressure reducing effects of piromelatine and melatonin in spontaneously hypertensive rats. Eur Rev Med Pharmacol Sci 2013;17:2449-2456.
21. PRUNET-MARCASSUS B, DESBAZEILLE M, BROS A, LOUCHE K, DELAGRANGE P, RENARD P, CASTEILLA L, PÉNICAUD L. Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology 2003;144:5347-5352.
22. RÍOS-LUGO MJ, CANO P, JIMÉNEZ-ORTEGA V, FERNÁNDEZ-MATEOS M P, SCACCHI PA, CARDINALI D P, ESQUIFINO AI. Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats. J Pineal Res 2010;49:342-348.
23. LEIBOWITZ A, PELEG E, SHARABI Y, SHABTAI Z, SHAMISS A, GROSSMAN E. The role of melatonin in the patho-genesis of hypertension in rats with metabolic syndrome. Am J Hypertens 2008;21:348-351.
24. GITTO E, PELLEGRINO S, GITTO P, BARBERI I, REITER RJ. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of mela-tonin. J Pineal Res 2009;46:128-39.
25. TAMURA H, TAKASAKI A, MIWA I, TANIGUCHI K, MAEKAWA R, ASADA H, TAKETANI T, MATSUOKA A, YAMAGATA Y, SHI-MAMURA K, MORIOKA H, ISHIKAWA H, REITER RJ, SUGINO N. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res 2008;44:280-287.
26. KEDZIORA-KORNATOWSKA K, SZEWCZYK-GOLEC K, KOZA-KIEWICZ M, PAWLUK H, CZUCZEJKO J, KORNATOWSKI T, BARTOSZ G, KEDZIORA J. Melatonin improves oxida-tive stress parameters measured in the blood of elderly type 2 diabetic patients. J Pineal Res 2009;46:333-337.
27. DE MOURA R F, RIBEIRO C, DE OLIVEIRA JA, STEVANATO E, DE MELLO MA. Metabolic syndrome signs in Wistar rats submitted to different high-fructose ingestion protocols. Br J Nutr 2009;101:1178-1184.
28. SUN Y, OBERLEY LW, LI Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500.
29. AEBI H. Catalase, In: Bergmeyer HU (Ed): Methods of Enzymatic Analysis, Academic Press, New York and London, 1974; pp. 673-677.
30. GRATTAGLIANO I, PALMIERI VO, PORTINCASA P, MOSCHET-TA A, PALASCIANO G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem 2008;19:491-504.
31. JOHNSON RJ, SEGAL MS, SAUTIN Y, NAKAGAWA T, FEIG DI, KANG DH, GERSCH MS, BENNER S, SÁNCHEZ-LOZA-DA LG. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007;86:899-906.
32. DEMIR B, DEMIR E, ACIKSARI G, UYGUN T, UTKU IK, GEDIKBASI A, CAGLAR IM, PIRHAN O, TURELI HO, OFLAR E, UNGAN I, CIFTCI S, KARAKAYA O. The association between the epicardial adipose tissue thickness and oxidative stress parameters in isolated metabolic syndrome patients: a multi-marker approach. Int J Endocrinol 2014;2014:954045.
33. VÁVROVÁ L, KODYDKOVÁ J, ZEMAN M, DUŠEJOVSKÁ M, MACÁŠEK J, STA KOVÁ B, TVRZICKÁ E, ZÁK A. Altered activities of antioxidant enzymes in patients with metabolic syndrome. Obes Facts 2013;6:39-47.
34. ZAKI ME, EL-BASSYOUNI H, KAMAL S, EL-GAMMAL M, YOUNESS E. Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents. Indian J En-docrinol Metab 2014;18:340-344.
35. SENTÍ M, TOMÁS M, FITÓ M, WEINBRENNER T, COVAS MI, SALA J, MASIÁ R, MARRUGAT J. Antioxidant paraox-onase 1 activity in the metabolic syndrome. J Clin Endocrinol Metab 2003;88:5422-5426.
36. VIELMA JR, BONILLA E, CHACÍN-BONILLA L, MORA M, MEDINA-LEENDERTZ S, BRAVO Y. Effects of melatonin on oxidative stress, and resistance to bacterial, parasitic, and viral infections: a review. Acta Trop 2014;137:31-38.
37. PABLOS MI, AGAPITO MT, GUTIERREZ R, RECIO JM, REIT-ER RJ, BARLOW-WALDEN L, ACUÑA-CASTROVIEJO D, MENENDEZ-PELAEZ A. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxi-dase in several tissues of chicks. J Pineal Res 1995;19:111-115.
38. SAILAJA DEVI MM, SURESH Y, DAS. Preservation of the antioxidant status in chemically-induced diabetes mellitus by melatonin. J Pineal Res 2000;29:108-115.
39. ANWAR MM, MEKI AR. Oxidative stress in streptozo-tocin-induced diabetic rats: effects of garlic oil and melatonin. Comp Biochem Physiol Mol Integr Physiol 2003;135:539-547.
40. KOTLER M, RODRÍGUEZ C, SÁINZ RM, ANTOLÍN I, MENÉN-DEZ-PELÁEZ A. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 1998;24:83-89.
41. ANTOLIN I, RODRIGUEZ C, SAINZ RM, MAYO JC, URIA H, KOTLER ML, RODRIGUEZ-COLUNGA MJ, TOLIVIA D, MENENDEZ-PELAEZ A. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J 1996;10:882-890.
42. OSSENI RA, RAT P, BOGDAN A, WARNET JM, TOUITOU Y. Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2. Life Sci 2000;68:387-399.
43. BARLOW-WALDEN LR, REITER RJ, ABE M, PABLOS M, MENENDEZ-PELAEZ A, CHEN LD, POEGGELER B. Mela-tonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995;26:497-502.
44. OZYURT H, OZYURT B, SARSILMAZ M, KUS I, SONGUR A, AKYOL O. Potential role of some oxidant/antioxi-dant status parameters in prefrontal cortex of rat brain in an experimental psychosis model and the protective effects of melatonin. Eur Rev Med Pharmacol Sci 2014;18:2137-2144.